Vincent Medical Holdings Limited

SEHK:1612 Voorraadrapport

Marktkapitalisatie: HK$274.4m

Vincent Medical Holdings Beheer

Beheer criteriumcontroles 3/4

De CEO Vincent Medical Holdings' is Raymond Choi, benoemd in Jan2023, heeft een ambtstermijn van 1.75 jaar. De totale jaarlijkse vergoeding van { bedraagt HK$ 1.52M, bestaande uit 80.8% salaris en 19.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.48% van de aandelen van het bedrijf, ter waarde HK$ 3.78M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 8.3 jaar.

Belangrijke informatie

Raymond Choi

Algemeen directeur

HK$1.5m

Totale compensatie

Percentage CEO-salaris80.8%
Dienstverband CEO1.8yrs
Eigendom CEO1.5%
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuur8.3yrs

Recente managementupdates

Recent updates

Vincent Medical Holdings Limited's (HKG:1612) Shares Lagging The Market But So Is The Business

Oct 04
Vincent Medical Holdings Limited's (HKG:1612) Shares Lagging The Market But So Is The Business

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Aug 23
Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

May 21
Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

Dec 21
Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Aug 29
Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

May 30
Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Dec 15
Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Aug 07
One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall

Aug 06
Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

May 25
Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Apr 27
Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Apr 07
Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive

Mar 08
Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive

Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term

Jul 27
Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term

Is Vincent Medical Holdings (HKG:1612) A Risky Investment?

Jun 06
Is Vincent Medical Holdings (HKG:1612) A Risky Investment?

One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%

Mar 28
One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%

Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Mar 25
Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital

Mar 23
Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital

Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?

Mar 04
Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?

I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease

Feb 17
I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease

Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?

Feb 04
Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?

What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition

Jan 22
What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition

Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%

Jan 08
Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%

Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 26
Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation

Dec 14
What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation

Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?

Dec 02
Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?

Analyse CEO-vergoeding

Hoe is Raymond Choi's beloning veranderd ten opzichte van Vincent Medical Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

HK$64m

Mar 31 2024n/an/a

HK$61m

Dec 31 2023HK$2mHK$1m

HK$57m

Compensatie versus markt: De totale vergoeding ($USD 194.87K ) Raymond } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 234.08K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Raymond te vergelijken met de prestaties van het bedrijf.


CEO

Raymond Choi (41 yo)

1.8yrs

Tenure

HK$1,515,000

Compensatie

Mr. Cheung Tai Choi, also known as Raymond, served as Deputy Chief Executive Officer of Vincent Medical Holdings Limited since January 1, 2022 until January 1, 2023 and serves as its Chief Executive Office...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Man Shing Choi
Executive Chairman8.9yrsHK$1.49m1.68%
HK$ 4.6m
Cheung Tai Choi
CEO & Executive Director1.8yrsHK$1.52m1.48%
HK$ 4.1m
Ming Fai Koh
VP of OEM Business & Executive Directorno dataHK$1.47m0.78%
HK$ 2.1m
Kwok Fu Fu
Executive Directorno dataHK$1.42m0.93%
HK$ 2.6m
Hoi Ming Lai
Chief Financial Officerno datageen gegevensgeen gegevens
Kar Kaan Liang
Associate Director of Operationsno datageen gegevensgeen gegevens
Yuk Ming Wong
Vice President of Sales & Marketingno datageen gegevensgeen gegevens
Wing Kwan Tsui
Head of Corporate Sustainability & Developmentno datageen gegevensgeen gegevens
Changqing Zhang
Head of Sales & Marketing of Greater China2.5yrsgeen gegevensgeen gegevens
Lai Ki Tsui
Company Secretary7.4yrsgeen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1612 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Man Shing Choi
Executive Chairman8.9yrsHK$1.49m1.68%
HK$ 4.6m
Cheung Tai Choi
CEO & Executive Director1.8yrsHK$1.52m1.48%
HK$ 4.1m
Ming Fai Koh
VP of OEM Business & Executive Director8.6yrsHK$1.47m0.78%
HK$ 2.1m
Kwok Fu Fu
Executive Director8.6yrsHK$1.42m0.93%
HK$ 2.6m
Yu Chiu Au
Independent Non-Executive Director8.3yrsHK$240.00kgeen gegevens
Kwok Cheung Mok
Independent Non-Executive Director8.3yrsHK$276.00kgeen gegevens
Kai Leung Yung
Independent Non-Executive Director7.7yrsHK$264.00kgeen gegevens
Ming Chu Leung
Non Executive Director1.3yrsHK$99.00kgeen gegevens

8.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1612 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.3 jaar).